Oramed Pharmaceuticals Inc. announced detailed results from its previously completed Phase 2a trial investigating ORMD-0801, its orally ingestible insulin capsule, in type 2 diabetes patients. The preliminary results of this trial were originally announced on Jan. 30, 2014
Researchers have developed a data-based model that accurately estimates A1c using self-monitored blood glucose (SMBG) readings, as described in Diabetes Technology & Therapeutics (DTT), a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
We’ve all heard the stories: a child or adult starts experiencing symptoms that seem to be nothing more than a cold or the flu. The doctor doesn’t catch the cycle of high blood sugars, and that spirals into hospitalization, often with dangerous diabetic ketoacidosis (DKA).
This study’s findings may help explain why a large-scale study found that very tight control of blood sugar levels in people with type 2 diabetes led to higher-than-expected death rates.
Some folks in the Diabetes Community report that their Transmitters aren’t showing the warning at all, while others say they only get a day or two out of the Transmitter once the low-battery message flashes on the iPod-esque Receiver screen.
On April 10, 2014 the U.S. Food & Drug Administration (FDA) issued a “Closeout” letter to Prodigy Diabetes Care to formally conclude the regulatory action that resulted in a Warning Letter on February 22, 2013.
Finger pricking and blood draws continue to be a daily ritual for millions of diabetics that require regular glucose testing. Yet, glucose is found in other bodily fluids and can be measured with appropriate tools. This has been difficult and costly, but researchers at the A*STAR research institute in Singapore have developed new technology that […]
Feeling peeved at your partner? You may want to check your blood sugar. A new study suggests that low levels of glucose in the blood may increase anger and aggression between spouses. The researchers say their findings suggest a connection between glucose and self-control, but other experts disagree about the study’s implications.
The insulin composition, delivery method, and local blood perfusion at the insulin delivery site all influence the absorption rate of insulin into the circulation. The current rapid-acting insulins we have aren’t particularly rapid compared with the body’s own insulin.
Last week, a company called UniStrip Technologies announced availability of a new FDA-approved generic test strip, and at the same time, we got word that the green-colored GenStrip alternative test strip we reported on in late 2012 is ramping up marketing after some courtroom successes
The GlucoTrack DF-F model is a high-tech earlobe clip that measures glucose using three kinds of technologies: ultrasound, electromagnetic, and thermal. You just clip the GlucoTrack sensor onto your earlobe and within a minute, it sends your BG data through a headphone-style cord to a smartphone-sized handheld controller.
Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care.
The drug, an inhaled powder, completed phase III testing in August of 2013. If approved, it will be the first ultra rapid-acting mealtime insulin therapy available in the United States.
On April 1, an FDA advisory panel gave a thumbs up to MannKind Corp.’s inhaled insulin Afrezza, which would be used specifically for meal-time doses to prevent post-prandial blood sugar spikes and would be quick and easy to dose via a tiny inhaler device that fits in the palm of your hand (and looks like […]
With the start of spring, you might be thinking about freshening up your diabetes hardware. Every year new meters, pens, pumps and continuous glucose monitors come to market.
The Diabetik app is a way for patients with diabetes to track and manage their disease. The app was created so that users can input their own data including medications taken, meals, blood glucose, activity, etc.
Glucagon injections are used to treat people with severe hypoglycemia who cannot swallow food or liquid due to sleepiness, unconsciousness, or seizures. However, mixing and administering the injection can be difficult for bystanders who don’t have medical training.
Nothing is perfect. That can certainly be said for the comprehensive front-health-page article the New York Times ran this Saturday, April 5, on the high cost of new type 1 diabetes tools.
Hayley is saving up for an important purchase: an updated version of the tiny digital pump at her waist that delivers lifesaving insulin under her skin. Such devices, which tailor insulin dosing more precisely to the body’s needs, have transformed the lives of people with Type 1 diabetes like Ms. Hayley.
A sweetener created from the same plant that brings us tequilacould help lower blood sugar and act as a weight-loss aid for those with type 2 diabetes, according to the results of a new study.